Oxford Gene Technology (OGT) has launched the latest versions of its Cytosure range of high resolution oligonucleotide arrays for cytogenetic syndromes and accurate whole genome aberration detection.
The Syndrome Plus v2 and Chromosome X high density arrays have been developed in close collaboration with leading cytogeneticists.
The Cytosure Syndrome Plus v2 array covers over 200 known cytogenetic syndrome regions, including 410 genes associated with autism, mental retardation, heart and eye diseases, with one probe every 3kb.
The array also offers extensive coverage of the whole genome, including subtelomeric regions and recombinant hotspots, with one probe every 40kb.
The Chromosome X high density array has a probe density of one probe every 2kb to target genes on the X chromosome, including exons, MiRNAs, RRNAs and SnRNAs.
Both arrays are available in 2 x 105k format.
Also available is analysis software that allows interpretation of results with data exchange for state-of-the-art cytogenetic profiling.
OGT offers total support from sample to result, as well as full training to users of Cytosure arrays.
